This time next month as many as 1,000 people a day could be receiving a  coronavirus  vaccine at the Etihad in Manchester

The Manchester Tennis and Football Centre in Sportcity Way will be converted into a mass Covid-19 vaccination centre starting in December.

More vulnerable members of the public and some NHS staff could receive their jab there before the year is out,  Manchester Evening News reported.

Most of the vaccinations in the city will be done by GPs.

Once the elderly and vulnerable have received their vaccines by the end of the month, they will have to return for a second boost after three weeks.

Some frontline health and social care staff will also be vaccinated at the centre if their employers cannot store the vaccines in freezers at minus 70 degrees.

The Manchester Tennis And Football Centre at the Etihad will be converted into a vaccination centre

The centre at the Etihad Stadium - home to Manchester City - will be run by Northern Care Alliance, the NHS group which runs hospitals in Salford, Oldham, Bury and Rochdale.

Chief nursing officer Libby McManus told the board that the project team is meeting at least three times a week and that "things are changing hourly".

She said: "My anticipation by this time next month is that we as a lead provider will have started vaccinating up to 1,000 people a day through the Etihad sports centre."

Plans for NHS staff vaccination are underway and could be ready by the end of the week.

Up to 1,000 a day could be vaccinated in at the Etihad

It is not currently clear where the majority of the NCA's 20,000 staff will be vaccinated.

NCA chief executive Raj Jain told the group's board that the mass vaccination programme is "moving at pace", having started just "seven or eight" days ago.

It was reported earlier today that NHS hospitals have been told to be ready to roll out a coronavirus vaccine from this Wednesday.

Sources have told the  Telegraph   that NHS Trusts "have been asked to mobilise" in anticipation of a roll out of the Pfizer/BioNTech vaccine.

It is possible that the jab could get regulatory approval in the UK this week.

Britain has ordered 40 million doses of the vaccine.